The genomic landscape of human immune-mediated diseases

Journal of Human Genetics

Volumn 60, Issue 11, 2015, Pages 675-681

  Wu, Xin ^a   Chen, Haiyan ^b   Xu, Huji ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; ETANERCEPT; GAMMA INTERFERON; HLA B27 ANTIGEN; HLA DQ2 ANTIGEN; HLA DR3 ANTIGEN; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 27; INTERLEUKIN 35; MYELOBLASTIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PENTRAXIN 3; PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; IL12A PROTEIN, HUMAN;

ALLERGIC ASTHMA; ANCA ASSOCIATED VASCULITIS; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CROHN DISEASE; DENDRITIC CELL; DISEASE ACTIVITY; EPIGENETICS; ETHNIC GROUP; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HAPLOTYPE MAP; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN GENOME; HUMAN GENOME PROJECT; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METHODOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PROTEIN INTERACTION; RACE; REGULATORY T LYMPHOCYTE; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS; ALLELE; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGY;

ALLELES; EPIGENESIS, GENETIC; ETHNIC GROUPS; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNE SYSTEM DISEASES; INTERLEUKIN-12 SUBUNIT P35; MAJOR HISTOCOMPATIBILITY COMPLEX; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84948185199     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2015.99     Document Type: Review

References (129)

1. Shurin, M. R. & Smolkin, Y. S. Immune-mediated diseases: where do we stand? Adv. Exp. Med. Biol. 601, 3-12 (2007).
2. Blandizzi, C., Gionchetti, P., Armuzzi, A., Caporali, R., Chimenti, S., Cimaz, R. et al. The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases. Int. J. Immunopathol. Pharmacol. 27 (suppl. 1), 1-10 (2014).
3. Torfs, C. P., King, M. C., Huey, B., Malmgren, J. & Grumet, F. C. Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am. J. Hum. Genet. 38, 170-187 (1986).
4. Lin, J. P., Cash, J. M., Doyle, S. Z., Peden, S., Kanik, K., Amos, C. I. et al. Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum. Genet. 103, 475-482 (1998).
5. Hemminki, K., Li, X., Sundquist, K. & Sundquist, J. Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum. 60, 2845-2847 (2009).
6. Thjodleifsson, B., Geirsson, A. J., Björnsson, S. & Bjarnason, I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 56, 2633-2639 (2007).
7. Elliott, D. E. & Weinstock, J. V. Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann. NY Acad. Sci. 1247, 83-96 (2012).
8. Robinson, D. Jr, Hackett, M., Wong, J., Kimball, A. B., Cohen, R. & Bala, M. IMID Study Group. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr. Med. Res. Opin. 22, 989-1000 (2006).
9. El-Gabalawy, H., Guenther, L. C. & Bernstein, C. N. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J. Rheumatol. Suppl. 85, 2-10 (2010).
10. Vizcarra, C. New perspectives and emerging therapies for immune-mediated inflammatory disorders. J. Infus. Nurs. 26, 319-325 (2003).
11. Van Wanrooij, R. L., Zwiers, A., Kraal, G. & Bouma, G. Genetic variations in interleukin-12 related genes in immune-mediated diseases. J. Autoimmun. 39, 359-368 (2012).
12. Ng, S. C., Bernstein, C. N., Vatn, M. H., Lakatos, P. L., Loftus, E. V. Jr, Tysk, C. et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 62, 630-649 (2013).
13. Versini, M., Jeandel, P. Y., Rosenthal, E. & Shoenfeld, Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13, 981-1000 (2014).
14. Padyukov, L., Silva, C., Stolt, P., Alfredsson, L. & Klareskog, L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 50, 3085-3092 (2004).
15. Diaz-Gallo, L. M. & Martin, J. Common genes in autoimmune diseases: a link between immune-mediated diseases. Expert Rev. Clin. Immunol. 8, 107-109 (2012).
16. Voight, B. F. & Cotsapas, C. Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity. Curr. Opin. Immunol. 24, 552-557 (2012).
17. Criswell, L. A., Pfeiffer, K. A., Lum, R. F., Gonzales, B., Novitzke, J., Kern, M. et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76, 561-571 (2005).
18. Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G. & Mortensen, P. B. Epidemiology of autoimmune diseases in Denmark. J. Autoimmun. 29, 1-9 (2007).
19. Becker, K. G. The common genetic hypothesis of autoimmune/inflammatory disease. Curr. Opin. Allergy Clin. Immunol. 1, 399-405 (2001).
20. Risch, N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 40, 1-14 (1987).
21. Altshuler, D. & Daly, M. Guilt beyond a reasonable doubt. Nat. Genet. 39, 813-815 (2007).
22. Wellcome Trust Case-Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
23. Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC), Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337 (2007).
24. Sorrentino, R. Genetics of autoimmunity: an update. Immunol. Lett. 158, 116-119 (2014).
25. Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661-673 (2013).
26. International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes, A., Hadler, J., Pointon, J. P., Robinson, P. C., Karaderi, T., et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730-738 (2013).
27. Ricaño-Ponce, I. & Wijmenga, C. Mapping of immune-mediated disease genes. Annu. Rev. Genom. Hum. Genet. 14, 325-353 (2013).
28. Hauser, S. L. Multiple lessons for multiple sclerosis. N. Engl. J. Med. 359, 1838-1841 (2008).
29. Kaprio, J., Tuomilehto, J., Koskenvuo, M., Romanov, K., Reunanen, A., Eriksson, J. et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 35, 1060-1067 (1992).
30. Kyvik, K. O., Green, A. & Beck-Nielsen, H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ. 311, 913-917 (1995).
31. Ebers, G. C., Bulman, D. E., Sadovnick, A. D., Paty, D. W., Warren, S., Hader, W. et al. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315, 1638-1642 (1986).
32. Horton, R., Wilming, L., Rand, V., Lovering, R. C., Bruford, E. A., Khodiyar, V. K. et al. Gene map of the extended human MHC. Nat. Rev. Genet. 5, 889-899 (2004).
33. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
34. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
35. Cotsapas, C. & Hafler, D. A. Immune-mediated disease genetics: the shared basis of pathogenesis. Trends Immunol. 34, 22-26 (2013).
36. Eyre, S., Bowes, J., Diogo, D., Lee, A., Barton, A., Martin, P. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44, 1336-1340 (2012).
37. Tsoi, L. C., Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341-1348 (2012).
38. Liu, J. Z., Almarri, M. A., Gaffney, D. J., Mells, G. F., Jostins, L., Cordell, H. J. et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 44, 1137-1141 (2012).
39. Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y. et al. Host - microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
40. Trynka, G., Hunt, K. A., Bockett, N. A., Romanos, J., Mistry, V., Szperl, A. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193-1201 (2011).
41. Mayes, M. D., Bossini-Castillo, L., Gorlova, O., Martin, J. E., Zhou, X., Chen, W. V. et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am. J. Hum. Genet. 94, 47-61 (2014).
42. Saruhan-Direskeneli, G., Hughes, T., Aksu, K., Keser, G., Coit, P., Aydin, S. Z. et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am. J. Hum . Genet. 93, 298-305 (2013).
43. Franke, L., van Bakel, H., Fokkens, L., de Jong, E. D., Egmont-Petersen, M. & Wijmenga, C. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am. J. Hum. Genet. 78, 1011-1025 (2006).
44. Lee, I., Blom, U. M., Wang, P. I., Shim, J. E. & Marcotte, E. M. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 21, 1109-1121 (2011).
45. Raychaudhuri, S., Plenge, R. M., Rossin, E. J., Ng, A. C., International Schizophrenia Consortium, Purcell, S. M. et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 5, e1000534 (2009).
46. Raychaudhuri, S., Thomson, B. P., Remmers, E. F., Eyre, S., Hinks, A., Guiducci, C. et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41, 1313-1318 (2009).
47. Rossin, E. J., Lage, K., Raychaudhuri, S., Xavier, R. J., Tatar, D., Benita, Y. et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 7, e1001273 (2011).
48. Cotsapas, C., Voight, B. F., Rossin, E., Lage, K., Neale, B. M., Wallace, C. et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 7, e1002254 (2011).
49. Van Sommeren, S., Janse, M., Karjalainen, J., Fehrmann, R., Franke, L., Fu, J. et al. Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways. Inflamm. Bowel Dis. 20, 987-994 (2014).
50. Middleton, D., Menchaca, L., Rood, H. & Komerofsky, R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens. 61, 403-407 (2003).
51. Price, P., Witt, C., Allcock, R., Sayer, D., Garlepp, M., Kok, C. C. et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167, 257-274 (1999).
52. Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205-1213 (1987).
53. Yang, Y., Chung, E. K., Zhou, B., Lhotta, K., Hebert, L. A., Birmingham, D. J. et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr. Dir. Autoimmun. 7, 98-132 (2004).
54. Capon, F., Di Meglio, P., Szaub, J., Prescott, N. J., Dunster, C., Baumber, L. et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122, 201-206 (2007).
55. Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41, 199-204 (2009).
56. Di Meglio, P., Di Cesare, A., Laggner, U., Chu, C. C., Napolitano, L., Villanova, F. et al. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS One 6, e17160 (2011).
57. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146 (2003).
58. Zwiers, A., Kraal, L., van de Pouw Kraan, T. C., Wurdinger, T., Bouma, G. & Kraal, G. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J. Immunol. 188, 1573-1577 (2012).
59. Zwiers, A., Fuss, I. J., Seegers, D., Konijn, T., Garcia-Vallejo, J. J., Samsom, J. N. et al. A polymorphism in the coding region of Il12b promotes IL-12p70 and IL-23 heterodimer formation. J. Immunol. 186, 3572-3580 (2011).
60. Plaza-Izurieta, L., Castellanos-Rubio, A., Irastorza, I., Fernández-Jimenez, N. & Gutierrez, G. CEGEC Revisiting genome wide association studies (GWAS) in coeliac disease: replication study in Spanish population and expression analysis of candidate genes. J. Med. Genet. 48, 493-496 (2011).
61. Namkung, J. H., Lee, J. E., Kim, E., Kim, S., Kim, S., Shin, E. S. et al. Association of single nucleotide polymorphisms in the IL-12 (IL-12A and B) and IL-12 receptor (IL-12Rbeta1 and beta2) genes and gene-gene interactions with atopic dermatitis in Koreans. J. Dermatol. Sci. 57, 199-206 (2010).
62. Gavett, S. H., O'Hearn, D. J., Li, X., Huang, S. K., Finkelman, F. D. & Wills-Karp, M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527-1536 (1995).
63. Hofstra, C. L., Van Ark, I., Hofman, G., Kool, M., Nijkamp, F. P. & Van Oosterhout, A. J. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 161, 5054-5060 (1998).
64. Niu, Q., Cai, B., Huang, Z. C., Shi, Y. Y. & Wang, L. L. Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol. Int. 32, 2731-2736 (2012).
65. Lubberts, E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine. 41, 84-91 (2008).
66. Zhou, Z. Y., Chen, S. L., Shen, N. & Lu, Y. Cytokines and Behcet's disease. Autoimmun. Rev. 11, 699-704 (2012).
67. Fransen, J. H., van der Vlag, J., Ruben, J., Adema, G. J., Berden, J. H. & Hilbrands, L. B. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res. Ther. 12, 207 (2010).
68. Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X. et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 60, 1472-1483 (2009).
69. Nguyen, C. Q., Hu, M. H., Li, Y., Stewart, C. & Peck, A. B. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum. 58, 734-743 (2008).
70. Sakai, A., Sugawara, Y., Kuroishi, T., Sasano, T. & Sugawara, S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J. Immunol. 181, 2898-2906 (2008).
71. Mieliauskaite, D., Dumalakiene, I., Rugiene, R. & Mackiewicz, Z. Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndrome. Clin. Dev. Immunol. 2012, 187258 (2012).
72. Miletic, M., Stojanovic, R., Pajic, O., Bugarski, D., Mojsilovic, S., Cokic, V. et al. Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome. Indian J. Med. Res. 135, 513-519 (2012).
73. Katsifis, G. E., Rekka, S., Moutsopoulos, N. M., Pillemer, S., Wahl, S. M. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am. J. Pathol. 175, 1167-1177 (2009).
74. Homey, B., Dieu-Nosjean, M. C., Wiesenborn, A., Massacrier, C., Pin, J. J., Oldham, E. et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621-6632 (2000).
75. Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092-1102 (2008).
76. Noack, M., Miossec, P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun. Rev. 13, 668-677 (2014).
77. Onishi, R. M., Gaffen, S. L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129, 311-321 (2010).
78. Raychaudhuri, S. P. Role of IL-17 in psoriasis and psoriatic arthritis. Clin. Rev. Allergy Immunol. 44, 183-193 (2013).
79. Zepp, J., Wu, L., Li, X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 32, 232-239 (2011).
80. Wang, Y. H., Wills-Karp, M. The potential role of interleukin-17 in severe asthma. Curr. Allergy Asthma Rep. 11, 388-394 (2011).
81. Shao, S., He, F., Yang, Y., Yuan, G., Zhang, M., Yu, X. Th17 cells in type 1 diabetes. Cell Immunol. 280, 16-21 (2012).
82. Molet, S., Hamid, Q., Davoine, F., Nutku, E., Taha, R., Pagé, N. et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108, 430-438 (2001).
83. Wang, Q., Li, H., Yao, Y., Xia, D., Zhou, J. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. J. Immunol. 185, 834-841 (2010).
84. Mewar, D., Wilson, A. G. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors. Br. J. Pharmacol. 162, 785-791 (2011).
85. Remouchamps, C., Boutaffala, L., Ganeff, C., Dejardin, E. Biology and signal transduction pathways of the lymphotoxin-αβ/LTβR system. Cytokine Growth Factor Rev. 22, 301-310 (2011).
86. Nash, P. T., Florin, T. H. Tumour necrosis factor inhibitors. Med. J. Aust. 183, 205-208 (2005).
87. Kuek, A., Hazleman, B. L., Ostör, A. J. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad. Med. J. 83, 251-260 (2007).
88. Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M. et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol. Immunol. 30, 1443-1453 (1993).
89. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025-4031 (1991).
90. Williams, R. O., Feldmann, M., Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 89, 9784-9788 (1992).
91. Papadakis, K.A., Targan, S.R. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119, 1148-1157 (2000).
92. Murch, S. H., Braegger, C. P., Walker-Smith, J. A., MacDonald, T. T. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 34, 1705-1709 (1993).
93. Fantuzzi, F., Del Giglio, M., Gisondi, P., Girolomoni, G. Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. Expert Opin. Ther. Targets 12, 1085-1096 (2008).
94. Chomarat, P., Dantin, C., Bennett, L., Banchereau, J., Palucka, A. K. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171, 2262-2269 (2003).
95. Cumberbatch, M., Dearman, R. J., Griffiths, C. E., Kimber, I. Langerhans cell migration. Clin. Exp. Dermatol. 25, 413-418 (2000).
96. Mascia, F., Mariani, V., Girolomoni, G., Pastore, S. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am. J. Pathol. 163, 303-312 (2003).
97. Pastore, S., Mascia, F., Mariani, V., Girolomoni, G. The epidermal growth factor receptor system in skin repair and inflammation. J. Invest. Dermatol. 128, 1365-1374 (2008).
98. Koshy, P. J., Henderson, N., Logan, C., Life, P. F., Cawston, T. E., Rowan, A. D. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann. Rheum. Dis. 61, 704-713 (2002).
99. O' Gradaigh, D., Ireland, D., Bord, S., Compston, J. E. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann. Rheum. Dis. 63, 354-359 (2004).
100. Sirota, M., Schaub, M. A., Batzoglou, S., Robinson, W. H., Butte, A. J. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet. 5, e1000792 (2009).
101. Wang, K., Baldassano, R., Zhang, H., Qu, H. Q., Imielinski, M., Kugathasan, S. et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum. Mol. Genet. 19, 2059-2067 (2010).
102. Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337-338 (2004).
103. Plagnol, V., Howson, J. M., Smyth, D. J., Walker, N., Hafler, J. P., Wallace, C. et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 7, e1002216 (2011).
104. Begovich, A. B., Carlton, V.E., Honigberg, L. A., Schrodi, S. J., Chokkalingam, A. P., Alexander, H. C. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330-337 (2004).
105. Jin, Y., Birlea, S. A., Fain, P. R., Gowan, K., Riccardi, S. L., Holland, P. J. et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N. Engl. J. Med. 362, 1686-1697 (2010).
106. Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
107. Jakkula, E., Leppä, V., Sulonen, A. M., Varilo, T., Kallio, S., Kemppinen, A. et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 86, 285-291 (2010).
108. Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F. et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488, 508-511 (2012).
109. Yamazaki, K., Onouchi, Y., Takazoe, M., Kubo, M., Nakamura, Y., Hata, A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J. Hum. Genet. 52, 575-583 (2007).
110. Davidson, S.I.∗, Wu, X.∗, Liu, Y., Wei, M., Danoy, P.A., Thomas, G. et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 60, 3263-3268 (2009).
111. Mori, M., Yamada, R., Kobayashi, K., Kawaida, R., Yamamoto, K. Ethnic differences in allele frequency of autoimmune-diseaseassociated SNPs. J. Hum. Genet. 50, 264-266 (2005).
112. Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C., Sturrock, R. D. Ankylosing spondylitis and HL-A 27. Lancet. 1, 904-907 (1973).
113. Caffrey, M. F., James, D. C. Human lymphocyte antigen association in ankylosing spondylitis. Nature 242, 121 (1973).
114. Schlosstein, L., Terasaki, P. I., Bluestone, R., Pearson, C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 288, 704-706 (1973).
115. Karvonen, J. HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbations after respiratory infections and occurrence of arthritis. Ann. Clin. Res. 7, 301-311 (1975).
116. Takano, M., Miyajima, T., Kiuchi, M., Ohmori, K., Amemiya, H. Behçet disease and the HLA system. Tissue Antigens. 8, 95-99 (1976).
117. Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
118. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
119. UK IBD Genetics Consortium, Barrett, J. C., Lee, J. C., Lees, C. W., Prescott, N. J., Anderson, C. A. et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat. Genet. 41, 1330-1334 (2009).
120. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J. P., Belaiche, J. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
121. Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
122. Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830-832 (2007).
123. Dechairo, B. M., Zabaneh, D., Collins, J., Brand, O., Dawson, G. J., Green, A. P. et al. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur. J. Hum. Genet. 13, 1223-1230 (2005).
124. Lyons, P. A., Rayner, T. F., Trivedi, S., Holle, J. U., Watts, R. A., Jayne, D. R. et al. Genetically distinct subsets within ANCA-associated vasculitis. N. Engl. J. Med. 367, 214-223 (2012).
125. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M. et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395-402 (2003).
126. Hreggvidsdottir, H. S., Noordenbos, T., Baeten, D. L. Inflammatory pathways in spondyloarthritis. Mol. Immunol. 57, 28-37 (2014).
127. Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156-163 (2007).
128. Uderhardt, S., Diarra, D., Katzenbeisser, J., David, J. P., Zwerina, J., Richards, W. et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann. Rheum. Dis. 69, 592-597 (2010).
129. Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).